UTI Large and Mid Cap Fund · Regular · Growth
NAV
₹176.9125
as of 29 Sept 2026
Expense Ratio
1.83%
AUM
₹5,924 Cr
Lumpsum returns (CAGR)
- 1Y
- +1.02%
- 3Y
- +12.76%
- 5Y
- +12.17%
- Since Inception
- +11.18%
SIP returns (XIRR)
- 1Y
- -4.38%
- 3Y
- +4.85%
- 5Y
- +11.72%
- Since Inception
- +11.70%
Returns calculated from 21 June 2019 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
What history actually did — last 10 years (Sept 2016 – Sept 2026)
A ₹5,000 monthly SIP for the last 10 years (Sept 2016 – Sept 2026)
Real NAV backtest
A ₹5,000 monthly SIP would be worth ₹12,68,141 today — ₹6,00,000 invested, 14.4% XIRR.
₹6,00,000
Invested
₹12,68,141
Value today
14.4%
XIRR (p.a.)
A ₹1,00,000 lumpsum, the last 10 years (Sept 2016 – Sept 2026)
Real NAV backtest
₹1,00,000 invested 10 years ago would be ₹3,37,862 today (13.0% CAGR).
A regular withdrawal plan (SWP)
Real NAV backtest
A ₹10,00,000 corpus withdrawing ₹5,000/month since Sept 2016 would still hold ₹21,10,476.
Fund vs Benchmark (TRI)
Same SIP, benchmark total-return index
The same SIP would be worth ₹12,68,141 in this fund vs ₹12,40,627 in the benchmark — outperformance of ₹10,879.
Buying the worst day
Real NAV backtest
₹1,00,000 invested on the worst market day of the last 10 years (Sept 2016 – Sept 2026) (22 Mar 2020) would be ₹4,50,526 today (4.50×).
Historical simulation using actual published NAVs for the stated period. Past performance may or may not be sustained in the future. Not investment advice.
Risk Metrics
Trailing 1 year, annualised0.17
Sharpe Ratio
+0.02
Alpha
0.37
Beta
0.16
Sortino
13.05%
Std Dev
-13.56%
Max Drawdown
Performance Comparison
Sectoral allocation
as of 31 Aug 2026- Banks16.62%
- Pharmaceuticals & Biotechnology8.86%
- IT - Software8.52%
- Finance6.16%
- Insurance5.73%
- Automobiles4.10%
- Construction3.85%
- Telecom - Services3.73%
- Petroleum Products3.72%
- Transport Services3.12%
- Power3.09%
- Capital Markets2.61%
Each sector links to the mutual funds most exposed to it.
Thinking about UTI Large and Mid Cap Fund · Regular · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
- 1Hdfc Bank Limited5.23%
- 2Icici Bank Ltd4.78%
- 3Reliance Industries Ltd.3.72%
- 4State Bank Of India3.07%
- 5Infosys Ltd.3.05%
- 6Larsen & Toubro Ltd.2.82%
- 7Aurobindo Pharma Ltd.2.58%
- 8Itc Ltd.2.46%
- 9Aditya Birla Capital Ltd2.34%
- 10Bharti Airtel Ltd.2.18%
What this fund does
UTI Large and Mid Cap Fund · Regular · Growth aims to achieve long-term capital appreciation by investing in both large-cap and mid-cap companies, with a minimum 35% allocation to each segment. This blend pairs the size of large-caps with the growth profile of mid-caps.
About This Fund
UTI Large and Mid Cap Fund · Regular · Growth is a Large & Mid Cap mutual fund offered by UTI Mutual Fund. The fund has been operational for over 33 years. It manages assets worth ₹5,924 Cr, reflecting investor confidence in the fund's strategy. It benchmarks its performance against Nifty LargeMidcap 250 TRI. The current expense ratio is 1.83%.
Who Should Invest?
- •Aggressive investors comfortable with significant short-term volatility
- •Investors with a long-term horizon of 7+ years who can ride out market cycles
- •SIP investors who can benefit from rupee cost averaging during market fluctuations